Direxion Daily S&P Biotech Bull 3x Shares ETF Newsroom

Short Stock Ideas From Each Sector With Earnings Quality in the Bottom 20%

Seeking AlphaNov 28 01:16

Natera Announces Its Prospera Lung Test Has Met Coverage Requirements From The Centers For Medicare & Medicaid Services' Molecular Diagnostics Services Program For Single Lung Transplant Recipients; This Coverage Applies To SLT Patients In The...

BenzingaNov 27 22:02

Trump Taps Jay Bhattacharya to Lead National Institutes of Health

Seeking AlphaNov 27 19:23

Needham Maintains Buy on Sarepta Therapeutics, Lowers Price Target to $202

BenzingaNov 27 18:40 · Ratings

Wolfe's Most Shorted 'Hit List' – FSLR, BE, WBA, SJM

Seeking AlphaNov 27 03:01

Dyne, Avidity Initiated at Outperform by RBC on DM1 Drugs

Seeking AlphaNov 27 02:03

Arrowhead Pharmaceuticals Shares Are On The Rise Today: What's Going On?

BenzingaNov 27 01:56

J.M. Smucker Posts Upbeat Earnings, Joins LexinFintech, Semtech, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday

BenzingaNov 27 00:15

How Is The Market Feeling About United Therapeutics?

BenzingaNov 26 21:15

Guardant Health Says Jury Unanimously Rejected All Of Natera's Counterclaims And Awarded $292.5M To Company, Including $175.5M In Punitive Damages

BenzingaNov 26 06:23

Guardant Health Shares Are Trading Higher After a Jury Issued a Decision in the Company's Favor Regarding a False Advertising Case Filed by Natera Concerning Statements Made About Guardant's Reveal Test.

BenzingaNov 26 04:58

Natera Issues Statement On Guardant Health Litigation; Says "A Jury Issued A Decision In Guardant's Favor. We Disagree With This Decision And Will Ask The Court To Overturn It"

BenzingaNov 26 04:53

Vertex Leads J.P. Morgan's Top Biotech Picks List for 2025

Seeking AlphaNov 26 04:10

Gilead Acquires Investigational HIV Vaccine From Spanish Biotech Aelix

Seeking AlphaNov 26 03:11

JPMorgan Updates Its U.S. Analyst Focus List – Adds TPR, ALRM, REG

Seeking AlphaNov 26 02:58

Looking Into Vertex Pharmaceuticals's Recent Short Interest

BenzingaNov 26 02:45

Incyte To Present Late-Breaking Tafasitamab Data In Follicular Lymphoma At ASH 2024 Alongside 20 Oncology Portfolio Updates, Including Phase 3 InMIND Results And Virtual Analyst Event On December 12

BenzingaNov 25 23:10

This Sarepta Therapeutics Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday

BenzingaNov 25 21:58

Price Over Earnings Overview: Gilead Sciences

BenzingaNov 25 21:15

Analyst Expectations For Sarepta Therapeutics's Future

BenzingaNov 25 21:01